Tick-Borne Disease Working Group Special Issue SECTION
Tick-Borne Disease Working Group Special Issue
How the LYMErix Lyme Disease Vaccine was Pulled from the Market
Patricia Smith, president of LDA, identifies lessons we can learn from the LYMErix Lyme disease vaccine story and pitfalls we can hopefully avoid in the future.
Balanced Lyme Disease Stories Benefit Tick-Borne Disease Working Group
The purpose of having balanced Lyme disease stories from Lyme patients is to provide some human interest to incentivize Congress to fund Lyme disease research.
Two Standards of Care for the Diagnosis and Treatment of Lyme Disease
LymeDisease.org’s Lorraine Johnson gave the following verbal comments about the two standards of care during the Tick-Borne Disease Working Group’s June 21 meeting.
Overview of the Tick-Borne Disease Working Group: What Has Been Accomplished so Far?
TBDWG subcommittees have been working nearly around the clock to ensure high-integrity reports will be ready for submission to Congress later this year and will include the most comprehensive viewpoints possible.
How the Patient Voice Has Impacted the Tick-Borne Disease Working Group
Patients are coming together to have an impact and create change in Lyme disease policy. The patient voice has a powerful impact on the future of Lyme.